Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends® Study of Over 4 Million Pregnancies
08:51am, Monday, 12'th Aug 2024
One in three women who tested positive for chlamydia or gonorrhea while pregnant were not retested before giving birth, despite potential to transmit infections to newborns SECAUCUS, N.J. , Aug. 12, 2
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?
10:15am, Monday, 05'th Aug 2024
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year
06:48am, Thursday, 01'st Aug 2024
Quest achieves top score of 100 on 2024 Disability Equality Index® Best Places to Work for Disability Inclusion SECAUCUS, N.J. , Aug. 1, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading
4 Stocks to Watch From a Challenging Outpatient Home Health Industry
11:41am, Wednesday, 31'st Jul 2024
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, EHC and ADUS are well-poised
DGX vs. PNTG: Which Stock Is the Better Value Option?
12:45pm, Tuesday, 30'th Jul 2024
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Quest Diagnostics (DGX) or The Pennant Group, Inc. (PNTG). But which of these two stoc
Are Investors Undervaluing Quest Diagnostics (DGX) Right Now?
10:45am, Monday, 29'th Jul 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, announced today a research collaboration with Dr. Simon Turcotte, hepatopancreat
Quest Diagnostics: Beat Down After Beating Q2 Estimates
05:40am, Sunday, 28'th Jul 2024
Quest Diagnostics: Beat Down After Beating Q2 Estimates
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
06:45am, Thursday, 25'th Jul 2024
Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J.
Quest Diagnostics' (DGX) Haystack Oncology Forges New MRD Deal
08:51am, Wednesday, 24'th Jul 2024
Quest Diagnostics' (DGX) subsidiary, Haystack Oncology, partners on the use of its MRD technology.
Quest Diagnostics' Q2 Earnings Performance Suggests Stable Stock, Modest Growth Ahead, Analyst Says
04:12pm, Tuesday, 23'rd Jul 2024
On Tuesday, Quest Diagnostics Inc DGX posted second-quarter adjusted EPS of $2.35, beating the consensus of $2.34.
Quest Diagnostics Incorporated (DGX) Q2 2024 Earnings Call Transcript
12:12pm, Tuesday, 23'rd Jul 2024
Quest Diagnostics Incorporated (NYSE:DGX ) Q2 2024 Earnings Conference Call July 23, 2024 8:30 AM ET Company Participants Jim Davis - Chairman, Chief Executive Officer, President Sam Samad - Chief Fin
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
11:06am, Tuesday, 23'rd Jul 2024
Quest Diagnostics (DGX) delivers impressive base business growth in the second quarter of 2024.
Quest Diagnostics (DGX) Q2 Earnings and Revenues Top Estimates
08:55am, Tuesday, 23'rd Jul 2024
Quest Diagnostics (DGX) came out with quarterly earnings of $2.35 per share, beating the Zacks Consensus Estimate of $2.31 per share. This compares to earnings of $2.30 per share a year ago.
Quest Diagnostics raises 2024 profit, revenue forecasts on health tests demand
08:19am, Tuesday, 23'rd Jul 2024
Quest Diagnostics raised its 2024 profit and revenue forecasts on Tuesday, banking on robust demand for its health tests.
